CNS Pharmaceuticals, Inc.(CNSP)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | Charles Faith L. Director | Purchase | +7,100 | +1126.98%7,730 | $4.79 | $34,002 | View SEC filing | |
| 2024-02-06 | Gumulka Jerzy Director | Purchase | +33,333 | +344.60%43,006 | $0.30 | $10,000 | View SEC filing | |
| 2024-02-06 | Evans Carl Anthony Director | Purchase | +33,333 | +26666.40%33,458 | $0.30 | $10,000 | View SEC filing | |
| 2024-02-06 | Downs Christopher Chief Financial Officer | Purchase | +66,666 | +181.30%103,438 | $0.30 | $20,000 | View SEC filing | |
| 2024-02-06 | Climaco John M Chief Executive Officer | Purchase | +166,666 | +340.07%215,676 | $0.30 | $50,000 | View SEC filing | |
| 2023-08-23 | Downs Christopher Chief Financial Officer | Purchase | +27,000 | +276.30%36,772 | $1.27 | $34,177 | View SEC filing | |
| 2023-08-16 | Climaco John M Chief Executive Officer | Purchase | +2,750 | +5.94%49,010 | $1.80 | $4,945 | View SEC filing | |
| 2023-08-01 | Priebe Waldemar 10% Owner | Sale | -94,298 | -37.55%156,807 | $1.41 | $133,114 | View SEC filing | |
| 2023-04-21 | Gumulka Jerzy Director | Purchase | +2,500 | +34.85%9,673 | $1.70 | $4,250 | View SEC filing | |
| 2023-04-18 | Downs Christopher Chief Financial Officer | Purchase | +3,100 | +50.40%9,251 | $3.20 | $9,920 | View SEC filing | |
| 2023-04-17 | Gumulka Jerzy Director | Purchase | +7,173 | +100.00%7,173 | $0.74 | $5,308 | View SEC filing | |
| 2023-04-14 | Climaco John M Chief Executive Officer | Purchase | +15,000 | +49.98%45,010 | $0.69 | $10,409 | View SEC filing | |
| 2021-12-07 | Downs Christopher Chief Financial Officer | Purchase | +5,000 | +3.41%151,500 | $0.94 | $4,702 | View SEC filing | |
| 2021-11-22 | Downs Christopher Chief Financial Officer | Purchase | +4,500 | +3.17%146,500 | $1.15 | $5,192 | View SEC filing | |
| 2020-08-25 | Downs Christopher Chief Financial Officer | Purchase | +142,000 | +100.00%142,000 | $2.04 | $289,680 | View SEC filing |
1-15 of 15